GBT
Showing 1 - 25 of 59
Sickle Cell Disease Trial (open-label GBT021601)
Not yet recruiting
- Sickle Cell Disease
- open-label GBT021601
- (no location specified)
Nov 21, 2022
Sickle Cell Disease Trial in Groningen (GBT021601)
Active, not recruiting
- Sickle Cell Disease
-
Groningen, NetherlandsICON Clinical Research Unit
Jan 30, 2023
Sickle Cell Disease Trial in Little Rock (GBT021601)
Recruiting
- Sickle Cell Disease
-
Little Rock, ArkansasLynn Institute of the Ozarks
Aug 10, 2022
Infantile Spinal Muscular Atrophy Trial in Garches (Mobility study in dry conditions, Mobility study in water conditions)
Not yet recruiting
- Infantile Spinal Muscular Atrophy
- Mobility study in dry conditions
- Mobility study in water conditions
-
Garches, FranceInfantile neuromuscular unity - Department of paediatric neurolo
Nov 21, 2023
Sickle Cell Disease Trial in Créteil (Voxelotor 1500 mg oral per day (GBT440) for 48 weeks in patients with sickle-cell disease)
Not yet recruiting
- Sickle Cell Disease
- Voxelotor 1500 mg oral per day (GBT440) for 48 weeks in patients with sickle-cell disease
-
Créteil, FranceHospital Henri Mondor
Jan 5, 2022
Periodontitis, Aggressive, Periodontal Diseases, Periodontitis Trial in Brescia (Airflow, Perioflow and Erythritol powder and
Completed
- Periodontitis, Aggressive
- +2 more
- Airflow, Perioflow and Erythritol powder and ultrasonic debridement
- Ultrasonic debridement and curettes
-
Brescia, Lombardia, ItalyMagda Mensi
Nov 3, 2021
Sickle Cell Disease Trial in Lebanon, United Kingdom, United States (Voxelotor)
Enrolling by invitation
- Sickle Cell Disease
-
Washington, District of Columbia
- +10 more
Sep 27, 2022
Idiopathic Pulmonary Fibrosis, Hypoxemia Trial in United States (GBT440, Placebo)
Completed
- Idiopathic Pulmonary Fibrosis
- Hypoxemia
- GBT440
- Placebo
-
Birmingham, Alabama
- +11 more
Sep 25, 2020
Idiopathic Pulmonary Fibrosis, Hypoxemia Trial in United Kingdom, United States (GBT440)
Terminated
- Idiopathic Pulmonary Fibrosis
- Hypoxemia
-
Birmingham, Alabama
- +8 more
Jul 31, 2020
Sickle Cell Disease Trial in Worldwide (voxelotor, Placebo)
Periodontitis Trial (Initial periodontal therapy and 3D intraoral scanning)
Not yet recruiting
- Periodontitis
- Initial periodontal therapy and 3D intraoral scanning
- (no location specified)
Feb 7, 2023
Sickle Cell Disease Trial in United States (Oxbryta® (voxelotor) 500mg Tablets)
Recruiting
- Sickle Cell Disease
- Oxbryta® (voxelotor) 500mg Tablets
-
Palo Alto, California
- +9 more
Dec 15, 2022
Plaque Trial in Brescia (Plaque Disclosing Agent, Airpolishing and ultrasonic debridement)
Completed
- Plaque
- Plaque Disclosing Agent
- Airpolishing and ultrasonic debridement
-
Brescia, Lombardia, ItalyMagda
Jun 20, 2022
Sickle Cell Disease, Leg Ulcers Trial in Kenya, Nigeria (Voxelotor Oral Tablet, Placebo)
Recruiting
- Sickle Cell Disease
- Leg Ulcers
- Voxelotor Oral Tablet
- Placebo
-
Kisumu, Western, Kenya
- +11 more
Sep 27, 2022
Mycobacterium Avium Complex Pulmonary Disease Trial in Seoul
Not yet recruiting
- Mycobacterium Avium Complex Pulmonary Disease
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jun 7, 2023
Sickle Cell Disease, Vaso-occlusive Crisis, Vaso-occlusive Pain Episode in Sickle Cell Disease Trial in Little Rock, Bronx,
Enrolling by invitation
- Sickle Cell Disease
- +2 more
-
Little Rock, Arkansas
- +2 more
Jun 30, 2022